Radius Recycling, Inc. (RDUS)
(Delayed Data from NSDQ)
$18.15 USD
-0.74 (-3.92%)
Updated May 20, 2024 04:00 PM ET
After-Market: $18.14 -0.01 (-0.06%) 5:32 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Brokerage Reports
[RDUS]
Reports for Purchase
Showing records 141 - 160 ( 169 total )
Industry: Medical - Drugs
Alobaloparatide-SQ on Track for US and EU Approvals in 2017; New PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: WERTHER C
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Promising Abaloparatide (ABL) Patch Data at ASBMR; Raising Price Target to $71 from $55
Provider: H.C. Wainwright & Co., Inc.
Analyst: WERTHER C
Industry: Medical - Drugs
ASBMR Weekend News Included Positive Data From KRN23 in TIO and Positive Subgroup Abaloparatide-SC ACTIVE Trial Result
Provider: H.C. Wainwright & Co., Inc.
Analyst: WERTHER C
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
We are initiating coverage of Radius Health Inc. with a Buy rating
Provider: H.C. Wainwright & Co., Inc.
Analyst: WERTHER C